Compounds > 1,10-phenanthroline
Page last updated: 2024-10-21

1,10-phenanthroline and Multiple Myeloma

1,10-phenanthroline has been researched along with Multiple Myeloma in 1 studies

1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wołoszyn, A1
Pettinari, C1
Pettinari, R1
Badillo Patzmay, GV1
Kwiecień, A1
Lupidi, G1
Nabissi, M1
Santoni, G1
Smoleński, P1

Other Studies

1 other study available for 1,10-phenanthroline and Multiple Myeloma

ArticleYear
Ru(ii)-(PTA) and -mPTA complexes with N
    Dalton transactions (Cambridge, England : 2003), 2017, Aug-14, Volume: 46, Issue:30

    Topics: 2,2'-Dipyridyl; Adamantane; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation;

2017